Navigation Links
New device creates lipid spheres that mimic cell membranes
Date:12/16/2011

Opening up a new door in synthetic biology, a team of researchers has developed a microfluidic device that produces a continuous supply of tiny lipid spheres that are similar in many ways to a cell's outer membrane. "Cells are essentially small, complex bioreactors enclosed by phospholipid membranes," said Abraham Lee from the University of California, Irvine. "Effectively producing vesicles with lipid membranes that mimic those of natural cells is a valuable tool for fundamental biology research, and it's also an important first step in the hoped-for production of an artificial cell." The researchers have taken an important step in advancing this field by developing a single system that quickly and efficiently performs all the necessary steps to create stable lipid vesicles. Current multistep production methods create vesicles that have inconsistent sizes and layers and short usable lifespans, and they are often contaminated with solvents used in their production.

A paper accepted for publication in the AIP's journal.

Biomicrofluidics reports that the new microfluidic design overcomes these previous hurdles by generating and manipulating precisely sized droplets of water in an oil environment. This produces an oil-and-water membrane that serves as a scaffold around which lipids molecules assemble. As the membrane dissolves over time, the accumulated lipids form a stable, uniform vesicle that shares many of a natural cell membrane's chemical and physical attributes.


'/>"/>
Contact: Charles Blue
cblue@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. Kount Receives Patent for Device Fingerprinting
2. Nanodiamond drug device could transform cancer treatment
3. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
4. Linking Proteins, Wires, Dots, and Molecules into Useful Devices
5. NC State finds new nanomaterial could be breakthrough for implantable medical devices
6. Futronic Launches FS22 Fingerprint Access Control Device
7. BIO-key(R) Granted Patent for Trusted Biometric Device Security Solution
8. NIST-Cornell team builds worlds first nanofluidic device with complex 3-D surfaces
9. Device protects transplanted pancreatic cells from the immune system
10. Chemical found in medical devices impairs heart function
11. MIT’s implantable device offers continuous cancer monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: